LEWIS, RUSSELL EDWARD
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 556
AS - Asia 210
EU - Europa 204
SA - Sud America 11
AF - Africa 3
Totale 984
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 556
SG - Singapore 135
IT - Italia 129
CN - Cina 47
GB - Regno Unito 17
FR - Francia 16
PL - Polonia 16
HK - Hong Kong 10
PE - Perù 8
TH - Thailandia 7
FI - Finlandia 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
DE - Germania 4
RU - Federazione Russa 4
AR - Argentina 3
ES - Italia 3
GH - Ghana 2
IN - India 2
KW - Kuwait 2
AT - Austria 1
JP - Giappone 1
LK - Sri Lanka 1
NL - Olanda 1
RO - Romania 1
SC - Seychelles 1
Totale 984
Salva come PNG Salva come JPEG
Città #
Santa Clara 155
Singapore 116
Fairfield 47
Boardman 42
Padova 36
Ashburn 24
Cambridge 19
Houston 19
Gdansk 16
Milan 16
Wilmington 15
Seattle 14
Woodbridge 13
Ann Arbor 12
Chandler 11
Beijing 9
Hong Kong 9
Kilburn 8
Lima 8
San Diego 8
Mestre 7
Naples 7
Camogli 6
Este 6
Abu Dhabi 5
London 5
Arezzo 4
Bologna 4
Guangzhou 4
Hat Yai 4
Medford 4
Ogden 4
Princeton 4
Romano d'Ezzelino 4
Treviso 4
Bangkok 3
Buenos Aires 3
Greenville 3
Helsinki 3
Lappeenranta 3
New York 3
Porto San Giorgio 3
Rimini 3
Rome 3
Roxbury 3
Weihai 3
Accra 2
Des Moines 2
Fie Allo Sciliar 2
Kuwait City 2
Livorno 2
Madrid 2
Moscow 2
Roseville 2
Turin 2
Verona 2
Amsterdam 1
Atlanta 1
Augusta 1
Battipaglia 1
Bengaluru 1
Bonate Sopra 1
Bonndorf 1
Bordeaux 1
Cologne 1
Columbus 1
Council Bluffs 1
Dalian 1
Frankfurt am Main 1
Hebei 1
Hounslow 1
Los Angeles 1
Mahé 1
Mong Kok 1
Mumbai 1
Nanjing 1
Nugegoda 1
Para 1
Phoenix 1
Prineville 1
San Jose 1
Springfield 1
Sudbury 1
Taunton 1
Tokyo 1
Venice 1
Villafranca di Verona 1
Totale 753
Salva come PNG Salva come JPEG
Nome #
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 102
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 96
Development of a Risk Prediction Model for Carbapenem-Resistant Enterobacteriaceae Infection after Liver Transplantation: A Multinational Cohort Study 54
Epidemiology of Invasive Pulmonary Aspergillosis among Intubated Patients with COVID-19: A Prospective Study 48
Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the European Hematology Association 46
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 45
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists 31
Clinical Approach to Infections in the Immunocompromised Host 27
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma 26
Breakthrough mucormycosis developing on mucorales-active antifungals portrays a poor prognosis in patients with hematologic cancer 25
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective 24
Chimeric antigen receptor T-cell therapy for the treatment of lymphoid malignancies: is there an excess risk for infection? 24
Management of drug–drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs 22
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in patients colonized with Candida spp 22
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium 22
Combination antifungal therapy for breakthrough invasive mould disease in patients with haematological malignancies: When management reasoning eclipses evidence-based medicine 22
Ceftolozane-tazobactam treatment of hypervirulent multidrug resistant pseudomonas aeruginosa infections in neutropenic patients 21
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 20
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales 20
Early low-dose computed tomography with pulmonary angiography to improve the early diagnosis of invasive mould disease in patients with haematological malignancies: A pilot study 19
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions 19
How long do we need to treat an invasive mold disease in hematology patients? factors influencing duration of therapy and future questions 18
Reply to Day et al 18
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 18
Identification and validation of diagnostic cutoffs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 16
Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia 16
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis 15
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 15
The lower respiratory tract microbiome of critically ill patients with COVID-19 15
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 14
Infectious disease consultation for candidaemia 13
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 13
Chimeric antigen receptor T-cell immunotherapy and need for prophylaxis for invasive mold infections 13
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion 12
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis 12
Triazole antifungal drug interactions - Practical considerations for excellent prescribing 11
Liposomal amphotericin B-the future 11
Successful Treatment of Paecilomyces variotii Pneumonia and Lupus Nephritis With Posaconazole-Cyclophosphamide Co-administration Without Drug Interaction–Induced Toxicity 11
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis 11
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress? 10
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study 9
Role and interpretation of antifungal susceptibility testing for the management of invasive fungal infections 7
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes 4
The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research 4
Systemic antifungal agents 4
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good? 4
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies 3
Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria 3
Preface 3
Preface 2
Preface 2
Totale 1.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.857
article - articoli 7.719
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 138
Totale 15.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 2 2 5 8 5 6 0
2020/202179 2 3 3 2 2 0 1 31 11 6 4 14
2021/202268 2 14 9 0 1 10 6 5 0 5 7 9
2022/2023117 8 3 1 1 4 3 0 2 2 86 2 5
2023/2024275 5 7 42 26 15 4 19 25 36 29 23 44
2024/2025448 8 115 26 47 162 90 0 0 0 0 0 0
Totale 1.042